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Background: Disease progression in cystic ﬁbrosis (CF) is marked by worsening exercise tolerance. Further, maximal exercise capacity (VO2
peak) correlates with survival in CF, but maximal tests are uncomfortable and resource-intensive. A three-minute step test (STEP) has been
validated in CF. Heart rate (HR) recovery after exercise correlates with all-cause mortality in adult non-CF populations. We compared HR recovery
after the three-minute step test with VO2 peak in children with CF.
Methods: : Twenty-four children with CF performed STEP and a maximal exercise test. Correlation between the tests was assessed.
Results: : Maximum HR on STEP was lower than on the maximal test (140 vs. 190, p b 0.01). Peak HR during STEP correlated inversely with
VO2 peak. In subjects with mild lung disease, faster HR recovery after STEP correlated with higher VO2 peak.
Conclusions: : The three-minute step test is a feasible submaximal test in this patient population. HR during and after a three-minute step test may
reﬂect VO2 peak in children with CF.
© 2014 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Cystic ﬁbrosis; Exercise testing; VO2max; heart rate recovery1. Introduction
Exercise intolerance is a hallmark of increasing disease severity
in patients with cystic fibrosis (CF) [1]. Further, exercise tolerance
is a robust correlate of mortality in CF [2,3]. Exercise tests are used
in a variety of cardiopulmonary diseases, including CF, to
determine functional capacity and causes for exercise intolerance,
and to evaluate disease progression and response to treatment [4].
The best studied measure of exercise tolerance in cystic fibrosis is
peak oxygen consumption (VO2 peak), as measured by a maximal
exercise test. Current recommendations state that patients with
cystic fibrosis should have a maximal exercise test annually [5].
However, a survey of German CF centers revealed that on average,
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as well as patients' dislike of the test itself [7]. In fact, in one study,
50% of subjects said that they would not want to perform a
maximal exercise test annually as recommended [8].
In light of the value of but significant problems with maximal
exercise tests, various submaximal tests that can be performed
outside an exercise physiology laboratory have been suggested for
patients with CF [9]. These tests have the added benefit of being
more reflective of usual physical activity patterns [10]. Both
six-minute walk tests and modified shuttle tests have been shown
to correlate with maximal exercise tests in patients with cystic
fibrosis [11–13]. However, walk tests and shuttle tests both require
a substantial amount of open space, and walk tests especially are
highly dependent on motivation and encouragement [14].
Step tests provide a possible solution to the space requirements
and motivation problems that plague walk tests and shuttle tests.
Step tests are not motivation dependent, are easy to perform, and




Age (years) 12.8 8–19
BMI (kg/m2) 17.7 14.9–23.3
Resting SpO2 98.6% 96–100%
Resting HR (bpm) 88 70–110
FEV1 (% predicted) 87% 36–111%
VO2 peak (% predicted) 110% 83–137%
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tially providing for better discrimination among relatively healthy
patients [16–18]. Holland et al. found that the three-minute step
test was able to predict 12-month outcomes in adults with CF [19].
However, even though the three-minute step test has been shown
to predict short-term outcomes in patients with CF, there are
currently no data correlating variables from the three-minute step
test with VO2 peak.
The only study to compare the three-minute step test and a
maximal test found that the step test was less strenuous than the
maximal exercise test. That study did not find a correlation
between heart rate (HR), SpO2, or breathlessness scores during
the three-minute-step test and VO2 peak [20].
Heart rate recovery after submaximal exercise is used in
non-CF adult populations as a measure of overall fitness, and has
even been shown to predict all-cause mortality in healthy adults
[21]. We designed this study to assess whether, among children
with cystic fibrosis, heart rate recovery after the three-minute step
test correlates with peak oxygen consumption. Hypotheses were
that in children 8 years and older with CF, a shorter time to return
to resting HR and a greater percent change frommaximumHR one
minute following the three-minute step test, a submaximal exercise
test, would correlate with greater percent predicted VO2 peak as
measured by a maximal exercise test.
2. Methods
Children 8 years of age and older with cystic fibrosis were
recruited from the Antonio J. and Janet Palumbo Cystic Fibrosis
Center at the Children's Hospital of Pittsburgh of UPMC. CF had
been diagnosed by sweat test, the presence of two disease-causing
mutations in the CFTR gene, or both. Exclusion criteria were
limited to major comorbidities, at the discretion of the subject's CF
clinician, or inability to perform reliable pulmonary function tests
or exercise tests.
Subjects performed either pre- and post-bronchodilator
spirometry or full pulmonary function tests, including lung
volumemeasurements, determined by clinical need and scheduling
constraints, immediately before the exercise testing. Written
informed consent was obtained from each subject's parent or legal
guardian or from the subjects themselves if they were over
eighteen years of age. Subjects under eighteen years of age
provided verbal or written assent. Subjects were shown how to
perform the stepping exercise, and then allowed a practice period.
The subjects then rested until a stable baseline resting heart rate
was reached and recorded, then each subject performed a
three-minute stepping exercise on a 15 cm step at a cadence of
30 complete steps (both feet on and off of the step) per minute.
Heart rate and oxyhemoglobin saturation were measured at rest,
during, and after the step test. Immediately after the exercise,
subjects were instructed to rest in a seated position until their heart
rate returned to within five beats per minute of their resting heart
rate. Subjects then performed a maximal oxygen consumption test
on a treadmill, using a modified Bruce protocol. At least ten
minutes were allowed between the step test and the maximal test.
Data were analyzed as a whole as well as after stratification
by FEV1. Desaturation was defined as a decrease in SpO2 ofgreater than 4%, and CO2 retention during the maximal test was
defined as rise in PETCO2 greater than 5 mm Hg as compared
to PETCO2 at rest. The maximum heart rate reached during the
three-minute step test was compared to the maximum heart rate
reached during the maximal exercise test with a paired two-
tailed student's t-test. Spearman's correlation coefficients were
calculated to assess correlation between variables. Stepwise
linear regression was performed to assess predictive value of
variables from the three-minute step test for maximal oxygen
consumption. A p-value of less than or equal to 0.05 was
considered significant.
3. Results
Twenty-four children (62% male) performed the three-minute
step test and a maximal exercise test. Subject characteristics may
be seen in Table 1.
All subjects were able to complete the three-minute step test,
with no adverse events or desaturations (fall in SpO2 N 4%).
Resting HR, but not FEV1, correlated with the maximum heart rate
reached during the step test (ρ = 0.436, p b 0.05 for resting HR).
No other subject characteristics correlated with outcome measures
from the step test. Fifty percent of subjects returned to their resting
HR less than one minute after completing the three-minute step
test.
All subjects were able to exercise maximally on the maximal
exercise test, as determined by their achieving of a respiratory
exchange ratio approximately equal to or greater than one. The
mean HR reached on the maximal exercise test was significantly
higher than the mean HR reached with the step test (190 vs 139,
p b 0.01— Fig. 1).
Subjects with a lower maximum heart rate on the three-minute
step test tended to have a higher percent predicted VO2 peak
(ρ = −0.40, p = 0.05, Fig. 2). Overall, time to resting HR after the
three-minute step test did not correlate with percent predicted VO2
peak. However, when stratified based on percent predicted FEV1,
interesting trends were revealed. In subjects with an FEV1 greater
than 80% predicted, a shorter time to return to resting heart rate
after the step test (faster HR recovery) correlated with higher
percent predicted VO2 peak (ρ = − .538, p b 0.05). This trendwas
also seen in subjects who did not retain CO2 during the maximal
test (ρ = −0.557, p b 0.05), though there was no correlation
between FEV1 and change in PETCO2 during exercise. On the
other hand, in subjects with an FEV1 of less than 80% predicted, a
longer time to return to resting heart rate after the step test (slower
HR recovery) actually correlated with a higher percent predicted
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Fig. 3. VO2 max (%predicted) vs. time to return to resting HR after the
three-minute step test, stratified by FEV1.
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significant differences between the subjects in different FEV1
categories that could explain this phenomenon (Fig. 3).
Increased age and height both correlated with lower percent
predicted VO2 peak (ρ = −0.46, p b 0.05 for age; ρ = −0.51,
p b 0.02 for height), and height and age were closely linked (ρ =
0.873, p b 0.02). However, age and height were not related to the
step test max HR. The three-minute step test max HR
alone was sufficient to predict percent predicted VO2 peak
(y = −0.578x + 191, p b 0.02), with no significant additional
predictive value gained from including height in the model.
4. Discussion
As all subjects were able to complete the three-minute step test
without any adverse events or desaturation, the three-minute step
test is a feasible test in this population. The maximum heart rate
reached on the three-minute step test was significantly lower than
the maximum heart rate reached during the maximal exercise test,
indicating that the three-minute step test truly is a submaximal test
for children and adolescents with cystic fibrosis. Narang et al. had
previously shown that there is not an order effect for the exercise
tests in this population [18]. As fifty percent of subjects returned toρ = -0.40
p = 0.05
Three-minute step test max HR
Fig. 2. VO2 max (%predicted) vs. three-minute step test max HR.resting heart rate within one minute of completing the three-minute
step test, change in percent of maximal heart rate at one minute
after the three-minute step test is not a useful measure of heart rate
recovery in children with cystic fibrosis, at least in those with
relatively mild lung disease and relatively good aerobic fitness, as
represented in our sample. Further studies on the role of heart rate
recovery in cystic fibrosis should include subjects with more
severe pulmonary impairment than our sample.
Maximum heart rate during the three-minute step test
emerged as a potentially useful measurement as regression
showed it was related to percent predicted VO2 peak. The story
with time to resting heart rate after the three-minute step test,
however, is not quite as simple. We predicted that the more
aerobically fit patients would have a quicker return of their
heart rate after exercise, and this proved to be true in the
children with mild lung disease (FEV1 N 80% predicted, and in
those who did not retain carbon dioxide during the maximal
exercise test). To our surprise, however, the relationship between
time to resting heart rate after the three-minute step test and percent
predicted VO2 peak behaves in exactly the opposite manner in
children with more severe lung disease (FEV1 b 80% predicted).
The relatively small sample size represented by the children with
more severe lung disease (n = 7) precluded further analysis of this
phenomenon. Future studies of the three-minute step test in
children with more severe CF lung disease and lower aerobic
fitness may help to elucidate why the children with more severe
lung disease seemed to oppose the expected trend.
Increased age (and therefore height) was related to a lower
maximal exercise capacity, likely reflective of the progressive
nature of the lung disease in cystic fibrosis. However, these
parameters were not associated with performance on the step test.
Though this study focused on evaluating the correlation
between the three-minute step test and maximal exercise tests,
submaximal field exercise tests like the three-minute step test are
uniquely poised to evaluate functional capacity because they are
more similar to typical activity patterns than are maximal tests [10].
Additionally, the simplicity and portability of the three-minute step
test makes it feasible to use as an office-based evaluation of
response to treatment [22]. Future studies could further investigate
applications of the three-minute step test in these areas.
715S.P. Cohen, D.M. Orenstein / Journal of Cystic Fibrosis 13 (2014) 712–715Holland et al. found that the 3-minute step test could predict
worse 12-month outcomes in adults with cystic fibrosis [19]. Since
maximal exercise tolerance has been shown to be strongly linked
to outcomes in cystic fibrosis, our study's finding that a 3-minute
step test correlates with maximal exercise tolerance fits with
previous literature and provides additional support to the further
exploration of the use of the three-minute step test in clinical
practice for patients with cystic fibrosis [2,3].
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